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THE OBSERVATION OF CONGENITAL RETROPERITONEAL LARGE 
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The article represents current literature data on epidemiological, clinical-morphological features and diagnostic criteria of neuroblas-
toma. The case of large congenital neuroblastoma with multiple metastases in the newborn child is presented. The histological picture 
and immunohistochemical profile of the tumor allowed us to consider this type of neuroblastoma as the least differentiated variant 
(subtype, “neuroblastoma rich in Schwann stroma”), with rapid progression and metastasizing started before the birth of the child.
Key Words: neuroblastoma, congenital tumor, tumors in children.
Neuroblastoma is an embryonal malignant tumor 
developing from the precursor cells of the sympa-
thetic nervous system (sympathogonia). It consti-
tutes 8–10% of all malignancies in children aged 
under 15 (7.8% in the USA, 9% in Germany, 9.3% 
in Belarus) [1–4], and in the structure of malignant 
extracranial tumors of childhood, according to some 
authors, is ranked first, ahead of leukemias [5].
More than 90% of tumors develop in children aged 
under 5 years, the peak of the disease occurs during 
the first year of life [6]. At the same time, the cases 
of neuroblastoma are described in adults and even 
in the elderly persons [7]. Neuroblastoma cases may 
be different by their clinical behavior with regressive, 
maturating or progressive types being delineated [8, 
9]. It is believed that regressive type characterized 
by generally favorable prognosis dominates in the 
children of the first year of life [10, 11].
In 70% of patients over 1 year, metastases to lymph 
nodes, liver, bone marrow and bones are revealed 
with the overall 5-year survival being less than 
40% [12]. In such cases, successful treatment cannot 
be achieved, even using intensive modes of high-dose 
therapy in combination with autologous bone marrow 
transplantation, or stem cells transplantation [13].
Microscopically, neuroblastoma is composed 
mainly of small rounded cells, with small rounded 
or oval nuclei surrounded by a narrow rim of cyto-
plasm (“naked nuclei”). The cancer cells are arranged 
irregularly, loosely or densely, depending on the 
amount of stroma. The rosette patterns (Homer Wright 
pseudorosettes) consisting of a halo of cancer cells 
surrounding a central region containing neuropil may 
be also seen. Axis cylinders usually cannot be found 
in the tumor. In addition to the above-described cell 
elements, a characteristic feature of this type of tumor 
is the presence of thin nerve fibers, but their detection 
in routine techniques used in the practical pathohisto-
logy, is almost impossible. Meanwhile, the presence 
of delicate nerve fibers is credible, pathognomonic, 
diagnostic sign. In connection with this sign, in most 
of the classic guides, the differential diagnosis of this 
type of tumors is recommended to be used as addi-
tional method of impregnation with silver salts [14–16].
Currently, immunohistochemical methods are 
widely used for the differential diagnosis of neuro-
blastoma with detection of neuronal markers such 
as neuron-specific enolase (NSE), synaptophysin, 
chromogranin A, СD56, СD57. It should be noted 
that the expression of S-100 protein and neurofila-
ment proteins occurs in more differentiated variants 
of tumors (ganglioneuroblastoma and ganglioneu-
roma) and Schwann stroma of low-grade neuroblas-
toma (subtype, “neuroblastoma that rich in Schwann 
stroma”) [17–20].
We present the case of congenital neuroblastoma 
of the retroperitoneal space, with large metastases, 
unrecognized in utero.
Baby T., a female, was treated at Children’s City 
Clinical Hospital with the diagnosis: congenital 
malignant tumor of the retroperitoneal space. The 
pregnancy of the mother was uneventful, the child 
was born in the City Clinical Maternity Hospital from 
the VII pregnancy (the third natural delivery, weight — 
2550 g, height — 44 cm, Apgar grade — 7/7 points. 
After the birth, the child’s condition worsened pro-
gressively, so she was moved to the intensive care 
unit of City Clinical Children’s Hospital. While being 
in the hospital, the child’s condition remained severe 
due to the progression of respiratory distress, the 
growing phenomena of malnutrition, partial intestinal 
obstruction.
The baby was examined clinically and instrumen-
tally. X-ray examination determined large size tumor 
formation in the abdominal cavity, with displacement 
loops of small bowel to the right. To clarify the diag-
nosis, biopsy of the tumor was performed.
Microscopic examination of tumor biopsy revealed 
small mostly rounded cells with a narrow rim of cyto-
plasm and small round nuclei. Sometimes, the oval 
cells were evident (Fig. 1, a). The cellular elements 
located randomly, occasionally forming pseudoro-
sette of Homer Wright (Fig. 1, b). Foci of necrosis and 
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hemorrhage were often seen in tumor tissue. At some 
sites, a well-defined stroma was evident forming a thin 
anastomosing alveolar structures (Fig. 1, c).
The above morphological and clinical data allowed 
to define the tumor as neuroblastoma, after which the 
child was assigned to symptomatic therapy. Treatment 
was not successful and on the 35 day after birth the 
child died.
On autopsy, in the left retroperitoneal space a gray-
ish-white mucus-like tumor sized 10.5 × 7 × 6.5 cm with 
numerous focuses of decay and hemorrhages was dis-
covered. The tumor extended into, left adrenal gland 
and left kidney, connecting with the head and body 
of the pancreas. The loops of the small bowel were 
displaced to the right by the tumor.
In the skin of the anterior abdominal wall, thighs, 
face, and neck area, dense whitish nodes sized from 
0.5 to 1.5 cm in diameter were revealed a, which were 
interpreted as metastases of the tumor. The micro-
scopic picture of the tumor and metastases was fully 
consistent with that described above.
To confirm the diagnosis, immunohistochemical 
examination with monoclonal antibodies to CD57, 
S-100, and NSE was performed. The reaction with 
CD57 in the majority of cancer cells was positive, 
S-100 was not expressed in cancer cells, but strong 
expression of S-100 was evident in the stromal com-
ponent of the tumor. The expression of NSE was ob-
served in the cellular elements of the tumor and in the 
stroma (Fig. 2).
Therefore, immunohistochemical studies con-
firmed the diagnosis previously made. Given the lack 
of S-100 expression in tumor cells and its pronounced 
expression instromal component of the tumor, this 
neuroblastoma case should be attributed to the least 
differentiated variant (subtype, “neuroblastoma rich 
in Schwann stroma”) [17–20]. Apparently, the low 
differentiation of the tumor resulted in rapid progres-
sion, copious metastasis even before the birth of the 
child. At the same time, it should be noted that usually 
poorly differentiated variants of neuroblastoma are not 
characteristic of children of the first year of life [10, 11].
a b c
Fig. 1. Microscopic structure of the tumor. Hematoxylin and eosin stain. a — cellular composition of the tumor; b — formation 
of Homer Wright pseudorosettes; c — alveolar structures in the tumor. × 400 (a, b), × 100 (c)
a b c
Fig. 2. Immunohistochemical profile of the tumor. a — expression of CD57 by tumor cells; b — lack of S-100 expression in tumor cells, 
expression of S-100 in the stromal component of the tumor; c — expression of NSE by tumor cells and stromal component, × 200
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